Literature DB >> 1769358

The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes.

J G Wetmur1, G Lehnert, R J Desnick.   

Abstract

The erythrocyte delta-aminolevulinate dehydratase (ALAD) isozyme phenotypes and the blood lead levels were determined in a population of 202 lead factory workers in Germany and an environmentally exposed population of 1278 children in New York who had elevated free protoporphyrin levels. In both population, individuals with the ALAD 1-2 or 2-2 isozyme phenotype had levels of blood lead statistically higher than those individuals with the ALAD 1-1 isozyme phenotype (lead workers: P greater than 0.004; children: P greater than 0.0001). Homozygotes and heterozygotes for the ALAD2 allele who expressed the 2-2 or 1-2 isozyme phenotype had median blood lead levels that were about 9 to 11 micrograms/dl greater than similarly exposed individuals who were homozygous for the ALAD1 allele. These findings support the hypothesis that the ALAD2 polypeptide binds lead more effectively, and therefore that individuals with the ALAD2 allele may be more susceptible to lead poisoning.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1769358     DOI: 10.1016/s0013-9351(05)80001-5

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  44 in total

Review 1.  Differential Susceptibility of the Developing Brain to Contextual Adversity and Stress.

Authors:  W Thomas Boyce
Journal:  Neuropsychopharmacology       Date:  2015-09-22       Impact factor: 7.853

2.  ALAD porphyria is a conformational disease.

Authors:  Eileen K Jaffe; Linda Stith
Journal:  Am J Hum Genet       Date:  2006-12-21       Impact factor: 11.025

3.  Genetic polymorphisms of GRIN2A and GRIN2B modify the neurobehavioral effects of low-level lead exposure in children.

Authors:  James P K Rooney; Nancy F Woods; Michael D Martin; James S Woods
Journal:  Environ Res       Date:  2018-04-11       Impact factor: 6.498

4.  delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.

Authors:  B S Schwartz; B K Lee; W Stewart; P Sithisarankul; P T Strickland; K D Ahn; K Kelsey
Journal:  Occup Environ Med       Date:  1997-04       Impact factor: 4.402

5.  Blood lead levels, ALAD gene polymorphisms, and mortality.

Authors:  Dana M van Bemmel; Yan Li; Jody McLean; Man-Huei Chang; Nicole F Dowling; Barry Graubard; Preetha Rajaraman
Journal:  Epidemiology       Date:  2011-03       Impact factor: 4.822

6.  ALAD genotypes and blood lead levels of neonates and children from e-waste exposure in Guiyu, China.

Authors:  Xia Huo; Lin Peng; Bo Qiu; Liangkai Zheng; Taofeek Akangbe Yekeen; Xijin Xu
Journal:  Environ Sci Pollut Res Int       Date:  2014-02-14       Impact factor: 4.223

7.  Lack of association of delta-aminolevulinic acid dehydratase genotype with cytogenetic damage in lead workers.

Authors:  Fang-Yang Wu; Pao-Wen Chang; Chin-Ching Wu; Jim-Shoung Lai; Hsien-Wen Kuo
Journal:  Int Arch Occup Environ Health       Date:  2004-07-16       Impact factor: 3.015

8.  Association of renal function and delta-aminolevulinic acid dehydratase polymorphism among Vietnamese and Singapore workers exposed to inorganic lead.

Authors:  S-E Chia; H J Zhou; E Yap; M T Tham; N-V Dong; N T Hong Tu; K-S Chia
Journal:  Occup Environ Med       Date:  2006-03       Impact factor: 4.402

9.  Applications of Tripodal [S(3)] and [Se(3)] L(2)X Donor Ligands to Zinc, Cadmium and Mercury Chemistry: Organometallic and Bioinorganic Perspectives.

Authors:  Gerard Parkin
Journal:  New J Chem       Date:  2007       Impact factor: 3.591

10.  Association between a polymorphism of aminolevulinate dehydrogenase (ALAD) gene and blood lead levels in Japanese subjects.

Authors:  Koichi Miyaki; Htay Lwin; Katsunori Masaki; Yixuan Song; Yoshimitsu Takahashi; Masaaki Muramatsu; Takeo Nakayama
Journal:  Int J Environ Res Public Health       Date:  2009-03-06       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.